Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05060341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05060341 · ClinicalTrials.gov record · last posted 2026-07-22

Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

StatusActive, Not Recruiting
PhaseNot specified
Started2020-11-12
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2021-09-24; most recent amendment 2026-07-21. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-04-15
Status change Enrolling by InvitationActive, Not Recruitingv3
Trial Details
NCT Number NCT05060341
Lead Sponsor MeiraGTx, LLC
Conditions Radiation-induced Xerostomia
Enrollment 22 participants
Start Date 2020-11-12
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-22